AKT1 and Hepatic fibrosis: Previous studies have found that the PI3K/Akt signaling pathway has the ability to proliferate HSC, reduce HSC apoptosis, and regulate the liver fibrosis progression by degrading ECM and increasing the expression levels of COLA1 and α-SMA[11,12].